Prot# AVF4167g: A Multicenter, Phase II, Randomized, Blinded, Placebo-Controlled Trial Evaluating the Efficacy and Safety of Sutent with or without Bevacizumab in First-Line Patients with Metastatic Renal Cell Cancer

  • Kuzel, Timothy Michael (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date9/12/07 → 9/12/10

Funding

  • ProTrials Research, Inc. (AVF4167g)
  • Genentech, Inc. (AVF4167g)